WASHINGTON (Oct. 7, 2025) — The George Washington University (GW) School of Medicine and Health Sciences, in partnership with Pfizer External Research and Grants, has announced two new opportunities to advance access to dermatologic care in underserved communities:
- A Request for Applications (RFA) for innovative teledermatology projects focused on bridging disparities in the care of chronic inflammatory skin diseases such as atopic dermatitis and alopecia areata.
- A Teledermatology Extension Award, offering $140,000 to one of the four past recipients of the GW/Pfizer Teledermatology Quality Improvement Grant, to continue and expand their successful programs.
In its first year, the GW/Pfizer Teledermatology Quality Improvement Grant assisted more than 200 patients nationwide to access dermatology care.
This initiative builds on GW’s pioneering Teledermatology Help Desk and Free Clinic model, which launched with an initial grant supported by Pfizer. That program established a recurring, community-based clinic in Washington, D.C., where patients learn how to access telehealth, optimize their technology, and connect directly with dermatologists and dermatology residents. Since its inception, the clinic has improved access to care for patients who otherwise face long wait times, financial barriers, or lack of local dermatology resources.
“For far too many individuals living with chronic inflammatory skin diseases, timely access to dermatologic care remains out of reach,” said Adam Friedman, M.D., Chair of the Department of Dermatology at GW SMHS and Director of the Teledermatology Grant Program. “Through this collaboration with Pfizer, we are not just funding proposals, we are investing in sustainable, community driven solutions that empower patients, train providers, and bridge the care divide. The extension award is a recognition that great ideas deserve the chance to grow, and together, we can make an enduring impact for those who need it most.”
Key Details:
- RFA Funding: Up to $250,000 for innovative teledermatology quality improvement initiatives.
- Extension Award: $140,000 for one prior grant recipient to expand or sustain their project.
- Eligibility: U.S.-based organizations with expertise in dermatology, telemedicine, and/or community engagement.
- Deadline: RFA Proposals due November 11, 2025 (11:59 PM EST); Extension Award proposal due October 14, 2025 (11:59 PM EST)
This unique collaboration between GW and Pfizer underscores a shared commitment to reducing health disparities and advancing equitable care delivery through innovation, education, and community partnerships.
For full application details and submission instructions, visit here: